Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy
纳武利尤单抗治疗既往接受过氟尿嘧啶和铂类化疗的不可切除的晚期、复发性或转移性食管鳞状细胞癌患者的获益风险总结
期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13646
Pelosof, Lorraine; Saung, May Tun; Donoghue, Martha; Casak, Sandra; Mushti, Sirisha; Cheng, Joyce; Jiang, Xiling; Liu, Jiang; Zhao, Hong; Khazraee, Maryam; Goldberg, Kirsten B; Theoret, Marc; Lemery, Steven; Pazdur, Richard; Fashoyin-Aje, Lola